Killer-cell immunoglobulin-like receptor polymorphism is associated with COVID-19 outcome: Results of a pilot observational study.
Niño-Ramírez JE, Alcoceba M, Gutiérrez-Zufiaurre MN, Marcos M, Gil-Etayo FJ, Bartol-Sánchez MR, Eiros R, Chillón MC, García-Álvarez M, Terradillos-Sánchez P, Presa D, Muñoz JL, López-Bernús A, López-Sánchez E, González-Calle D, Sánchez PL, Compán-Fernández O, González M, García-Sanz R, Boix F.
Niño-Ramírez JE, et al. Among authors: munoz jl.
HLA. 2024 Aug;104(2):e15640. doi: 10.1111/tan.15640.
HLA. 2024.
PMID: 39148254